The Clinical Trials in Oncology East Coast 2026 conference brings together oncology research leaders, clinical trial operations professionals, biotechnology and pharmaceutical experts, and solution providers to address the latest advancements and challenges in oncology clinical trials. This event offers sessions on innovation, patient-centric strategies, and collaboration to help optimize clinical trial design and execution across the oncology landscape.
Oncology Make-or-Break Moments: Development Decisions That Determine Whether a Program Accelerates…or Stalls
In oncology drug development, programs rarely fail because of a single operational mistake; they stall when critical decisions are delayed at key inflection points. This session explores the make-or-break moments that shape a program’s trajectory, from first-in-human readouts and expansion cohort strategy to protocol amendments, geographic expansion, and Phase II planning. Dr. Edward Dow will discuss how sponsors can integrate clinical, regulatory, competitive, commercial, and market access perspectives to make faster, more informed go/no-go decisions. Attendees will learn practical approaches to identifying differentiation early, reducing uncertainty, and accelerating development in an increasingly competitive oncology landscape.
Speaker Info: Ed Dow, MD
Date + Time: July 1st, 2026 – 12:00-12:30pm